Skip to content
August 15, 2022

Equity.Guru

Investment information for the new generation

BioVaxys - 14-06- Press Release Thumbnails

VIDEO: BioVaxys Technology (BIOV.C) Receives Positive FDA Response

BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has reviewed its pre-IND request for a Type B review of the Company’s Covid-T™ program. Read full article here: https://equity.guru/2021/06/14/biovaxys-technology-biov-c-receives-positive-fda-response/

More on

Leave a Reply

Your email address will not be published.